TPG Healthcare Partners II, L.P.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$2.4B
Investors
95
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
TPG Healthcare Partners II, L.P. is a Delaware limited partnership that first filed a Form D on April 29, 2022 and most recently amended it on November 16, 2023, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(7) and covers pooled investment fund interests. TPG Healthcare Partners II, L.P. reported $2,433,835,510 sold from 95 investors in an offering of indefinite size as of the Form D filed November 16, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED (CRD 7691), associated with None as the recipient of sales compensation soliciting in all states. The issuer's address of record is 301 Commerce Street, Suite 3300, Fort Worth, TX 76102.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing November 16, 2023
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Fund family Part of the TPG Healthcare Partners family: 6 vehicles across 2 generations · adviser of record Tpg Capital Advisors, LLC · full family and the filing behind each link in the terminal
Investor
- The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
- The dated record: 23 facts with source, effective date and capture date, viewable as AltStreet knew them on any past day
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Adviser of Record (Form ADV)
CRD 159738 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a private equity fund
Auditor named on Form ADV: Deloitte & Touche LLP · PCAOB-registered per the adviser
From the adviser's Form ADV as loaded from the SEC bulk data, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2023-11-16: 1 related person added and 4 removed against the filing of 2022-11-28; 6 now listed. The names are in the Terminal feed.
TPG Healthcare Partners GenPar II, L.P.
Executive Officer, Director, Promoter · Fort Worth, TX
The Issuer's General Partner
TPG Healthcare Partners GenPar II Advisors, LLC
Executive Officer, Director · Fort Worth, TX
General Partner of the Issuer's GP
Martin Davidson
Executive Officer · Fort Worth, TX
Officer of the General Partner of the Issuer's GP
Joann Harris
Executive Officer · Fort Worth, TX
Officer of the General Partner of the Issuer's GP
Steven A Willmann
Executive Officer · Fort Worth, TX
Officer of the General Partner of the Issuer's GP
Jordan A Kolar
Executive Officer · New York, NY
Officer of the General Partner of the Issuer's GP
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATEDCRD 7691 on BrokerCheck
Associated broker-dealer: None · New York, NY · Soliciting in all states
Questions About TPG Healthcare Partners II, L.P.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is TPG Healthcare Partners II, L.P.?
TPG Healthcare Partners II, L.P. is a Delaware limited partnership that filed a Form D with the SEC on November 16, 2023 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of pooled investment fund interests.
Is TPG Healthcare Partners II, L.P. legit?
AltStreet does not rate legitimacy; it reports the public record. TPG Healthcare Partners II, L.P. filed a Form D with the SEC on November 16, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $2,433,835,510 sold to 95 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is TPG Healthcare Partners II, L.P. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that TPG Healthcare Partners II, L.P. claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has TPG Healthcare Partners II, L.P. raised?
TPG Healthcare Partners II, L.P. reported $2,433,835,510 sold from 95 investors in an offering of indefinite size as of the Form D filed November 16, 2023.
Who can invest in TPG Healthcare Partners II, L.P.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in TPG Healthcare Partners II, L.P.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling TPG Healthcare Partners II, L.P. and how are they paid?
The Form D names MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED (CRD 7691), associated with None as the recipient of sales compensation soliciting in all states.
Who is behind TPG Healthcare Partners II, L.P.?
The Form D lists 6 related persons: TPG Healthcare Partners GenPar II, L.P., executive officer, director, promoter (The Issuer's General Partner); TPG Healthcare Partners GenPar II Advisors, LLC, executive officer, director (General Partner of the Issuer's GP); Martin Davidson, executive officer (Officer of the General Partner of the Issuer's GP); Joann Harris, executive officer (Officer of the General Partner of the Issuer's GP); Steven A Willmann, executive officer (Officer of the General Partner of the Issuer's GP); Jordan A Kolar, executive officer (Officer of the General Partner of the Issuer's GP). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is TPG Healthcare Partners II, L.P. located?
The issuer's address on its SEC filings is 301 Commerce Street, Suite 3300, Fort Worth, TX 76102. Its phone number of record is (817) 871-4000. It is organized under the laws of Delaware.
How long is the TPG Healthcare Partners II, L.P. offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.
How large is TPG Healthcare Partners II, L.P.?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.